APA (7th ed.) Citation

Gargiulo, L., Ibba, L., Alfano, A., Malagoli, P., Amoruso, F., Balato, A., . . . Maurelli, M. (2024). Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: Results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis). Journal of Dermatological Treatment, 35(1), 1. https://doi.org/10.1080/09546634.2024.2411855

Chicago Style (17th ed.) Citation

Gargiulo, Luigi, et al. "Short-term Effectiveness and Safety of Abrocitinib in Adults with Moderate-to-severe Atopic Dermatitis: Results from a 16-week Real-world Multicenter Retrospective Study – Il AD (Italian Landscape Atopic Dermatitis)." Journal of Dermatological Treatment 35, no. 1 (2024): 1. https://doi.org/10.1080/09546634.2024.2411855.

MLA (9th ed.) Citation

Gargiulo, Luigi, et al. "Short-term Effectiveness and Safety of Abrocitinib in Adults with Moderate-to-severe Atopic Dermatitis: Results from a 16-week Real-world Multicenter Retrospective Study – Il AD (Italian Landscape Atopic Dermatitis)." Journal of Dermatological Treatment, vol. 35, no. 1, 2024, p. 1, https://doi.org/10.1080/09546634.2024.2411855.